Literature DB >> 11798067

Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis.

C Mailhos1, U Modlich, J Lewis, A Harris, R Bicknell, D Ish-Horowicz.   

Abstract

Delta-Notch signalling regulates cell-fate choices in a variety of tissues during development. We report the expression of Delta4 (D14) in arterial endothelium during mouse embryogenesis and in the endothelium of tumor blood vessels. The expression of D14 in the mouse begins at 8 dpc in the dorsal aortae, umbilical artery and the heart. Subsequent expression is restricted to smaller vessels and capillaries and is reduced in most adult tissues. However, it is high in the vasculature of xenograft human tumors in the mouse, in endogenous human tumors and is regulated by hypoxia. These data implicate D14 and the Notch signalling pathway in angiogenesis and suggest possible new targets for antiangiogenic tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11798067     DOI: 10.1046/j.1432-0436.2001.690207.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  95 in total

1.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation.

Authors:  Luika A Timmerman; Joaquín Grego-Bessa; Angel Raya; Esther Bertrán; José María Pérez-Pomares; Juan Díez; Sergi Aranda; Sergio Palomo; Frank McCormick; Juan Carlos Izpisúa-Belmonte; José Luis de la Pompa
Journal:  Genes Dev       Date:  2003-12-30       Impact factor: 11.361

2.  Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression.

Authors:  Michela Noseda; Linda Chang; Graeme McLean; Jonathan E Grim; Bruce E Clurman; Laura L Smith; Aly Karsan
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 3.  Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis.

Authors:  Jennifer J Tung; Ian W Tattersall; Jan Kitajewski
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

4.  Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization.

Authors:  Hongyuan Mao; James J Graziano; Tyson M A Chase; Cornelia A Bentley; Omar A Bazirgan; Neil P Reddy; Byeong Doo Song; Vaughn V Smider
Journal:  Nat Biotechnol       Date:  2010-10-24       Impact factor: 54.908

5.  Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia.

Authors:  Ayman Al Haj Zen; Atsuhiko Oikawa; Miriam Bazan-Peregrino; Marco Meloni; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2010-05-27       Impact factor: 17.367

6.  Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.

Authors:  Kyla Driscoll Carroll; Wei Bu; Diana Palmeri; Sophia Spadavecchia; Stephen J Lynch; Salvatore A E Marras; Sanjay Tyagi; David M Lukac
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Negative feedback regulation of Met-dependent invasive growth by Notch.

Authors:  M Cristina Stella; Livio Trusolino; Selma Pennacchietti; Paolo M Comoglio
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 8.  Cardiovascular genomics: a current overview of in vivo and in vitro studies.

Authors:  Devi Mariappan; Johannes Winkler; Jürgen Hescheler; Agapios Sachinidis
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 9.  Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.

Authors:  Wen Shi; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

10.  RUNX3 maintains the mesenchymal phenotype after termination of the Notch signal.

Authors:  YangXin Fu; Alex Chia Yu Chang; Michèle Fournier; Linda Chang; Kyle Niessen; Aly Karsan
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.